Biotech Values

[pharmaclown35]

i agree. Somaxon also has an unpartnered sleep drug. merck scrapped their drug a couple of years ago, the one partnered with lundbeck. neurogen ran into problems with their insomnia drug adipilion.

insomnia drugs aren't getting partnered these days. too high of a risk at the FDA.

also, cardiovascular drugs are also taking a beating lately. i wonder when the agency will announce anything on prasugrel.

still waiting...